Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer [NA]
A completed clinical trial assessing how geriatric factors influence radiotherapy outcomes in patients over 75 with prostate cancer. Phase i…
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)
Terminated feasibility trial evaluating measurement of tumor blood flow via positron activation after proton therapy in brain, prostate, and…
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer [Phase 2]
Phase 2 trial of dasatinib (Sprycel) in hormone-refractory prostate cancer completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer [Phase 3]
Phase 3 trial comparing cabozantinib (XL184) to mitoxantrone plus prednisone in men with previously treated symptomatic castration-resistant…
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: Biomarkers in Prostate Cancer Treated With SRP Following Failure of FAT
This document provides an update on a prostate cancer clinical trial examining biomarkers in patients treated with SRP after failure of FAT.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-05-22FDA Approved: YONSA — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approval of Sun Pharmaceutical Industries' YONSA (abiraterone acetate) under an Original Application for the treatment of prostate cance…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer [Phase 2]
A Phase 2 randomized trial comparing castration alone to castration plus metformin as first-line therapy in advanced prostate cancer has com…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique?
This completed clinical trial compares end-fire versus side-fire ultrasound-guided biopsy techniques for detecting prostate cancer at the fi…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating ipilimumab in combination with androgen suppression therapy for metastatic hormone-resistant prostate canc…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Comparison of Volume Controlled Ventilation With 1:1 Inspiratory to Expiratory Ratio and Autoflow-volume Controlled Ventilation in Robot-assisted Laparoscopic Radical Prostatectomy With Steep Trendelenburg Position and Pneumoperitoneum [NA]
This clinical trial update notes the completion of a study comparing two ventilation strategies during robot-assisted laparoscopic radical p…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer [Phase 3]
A completed Phase 3 trial evaluated whether adding goserelin to radiation therapy improves outcomes in patients who have undergone surgery f…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Pilot Study of SBRT and CDX-1127 in Prostate Cancer [Phase 1]
Phase 1 pilot study evaluating SBRT with CDX-1127 for prostate cancer has been terminated.
-
CLINICAL_TRIALS research · 2018-05-17Clinical Trial Update: A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating 18F-AlF-NOTA-Neurotensin PET/CT for imaging prostate cancer; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment [Phase 1, Phase 2]
A clinical trial is evaluating an investigational therapeutic vaccine in combination with PD-1 knockout for prostate cancer in Phase 1/2, sp…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
This clinical trial update notes how management decisions for recurrent prostate cancer may be guided by results from [11C]Acetate PET scans…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer [Phase 2]
Phase 2 trial update on exisulind with intermittent androgen suppression in biochemical relapsed prostate cancer.
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer [Phase 2]
Phase 2 trial update on effects of IAS in men with localized biochemical relapsed prostate cancer; trial completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of bortezomib and docetaxel in patients with hormone-refractory prostate cancer; the study…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy [NA]
A completed prospective trial comparing extended pelvic lymphadenectomy with limited pelvic lymphadenectomy in intermediate- and high-risk p…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer Patients [NA]
A completed clinical trial evaluated whether yoga counselling improves quality of life and psychological outcomes in prostate cancer patient…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: PSA TOOL for Prostate Cancer Screening Discussions [NA]
This clinical trial update notes the completion of a study evaluating a PSA tool to aid discussions about prostate cancer screening.
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer [Phase 2]
Phase 2 study evaluating the safety and efficacy of TAK-385 together with leuprorelin in prostate cancer has completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Atorvastatin Before Prostatectomy and Prostate Cancer [Phase 2]
Phase 2 study evaluating atorvastatin given before prostatectomy in patients with prostate cancer has completed. The trial was conducted at …
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT) [NA]
This document provides an update on a pilot study evaluating whether increased physical activity can improve quality of life in prostate can…
-
CLINICAL_TRIALS research · 2018-05-04Clinical Trial Update: Prostate Cancer Survivors Moving Toward Exercise (PROMOTE) Trial [NA]
The PROMOTE trial investigated exercise interventions for prostate cancer survivors. The study status is completed.